These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25895584)

  • 1. Global- and renal-specific sympathoinhibition in aldosterone hypertension.
    Lohmeier TE; Liu B; Hildebrandt DA; Cates AW; Georgakopoulos D; Irwin ED
    Hypertension; 2015 Jun; 65(6):1223-30. PubMed ID: 25895584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure.
    Lohmeier TE; Hildebrandt DA; Dwyer TM; Barrett AM; Irwin ED; Rossing MA; Kieval RS
    Hypertension; 2007 Feb; 49(2):373-9. PubMed ID: 17159083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged Baroreflex Activation Abolishes Salt-Induced Hypertension After Reductions in Kidney Mass.
    Hildebrandt DA; Irwin ED; Lohmeier TE
    Hypertension; 2016 Dec; 68(6):1400-1406. PubMed ID: 27777356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.
    Lohmeier TE; Dwyer TM; Hildebrandt DA; Irwin ED; Rossing MA; Serdar DJ; Kieval RS
    Hypertension; 2005 Nov; 46(5):1194-200. PubMed ID: 16216987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged activation of the baroreflex abolishes obesity-induced hypertension.
    Lohmeier TE; Dwyer TM; Irwin ED; Rossing MA; Kieval RS
    Hypertension; 2007 Jun; 49(6):1307-14. PubMed ID: 17438305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of renin secretion and arterial pressure during prolonged baroreflex activation: influence of salt intake.
    Hildebrandt DA; Irwin ED; Cates AW; Lohmeier TE
    Hypertension; 2014 Sep; 64(3):604-9. PubMed ID: 24935941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of global versus renal-specific sympathoinhibition in aldosterone-induced hypertension: implications for medical device-based treatment of resistant hypertension.
    Carmichael CY; Wainford RD
    Hypertension; 2015 Jun; 65(6):1160-2. PubMed ID: 25895585
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and renal-specific sympathoinhibition in obesity hypertension.
    Lohmeier TE; Iliescu R; Liu B; Henegar JR; Maric-Bilkan C; Irwin ED
    Hypertension; 2012 Feb; 59(2):331-8. PubMed ID: 22184321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal responses to chronic suppression of central sympathetic outflow.
    Iliescu R; Irwin ED; Georgakopoulos D; Lohmeier TE
    Hypertension; 2012 Sep; 60(3):749-56. PubMed ID: 22753216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the heart in blood pressure lowering during chronic baroreflex activation: insight from an in silico analysis.
    Clemmer JS; Pruett WA; Hester RL; Iliescu R; Lohmeier TE
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1368-H1382. PubMed ID: 30004810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension.
    Grassi G; Turri C; Dell'Oro R; Stella ML; Bolla GB; Mancia G
    J Hypertens; 1998 Dec; 16(12 Pt 1):1789-96. PubMed ID: 9869013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of sustained hypertension by chronic intrarenal norepinephrine infusion in conscious dogs.
    Katholi RE; Carey RM; Ayers CR; Vaughan ED; Yancey MR; Morton CL
    Circ Res; 1977 May; 40(5 Suppl 1):I118-26. PubMed ID: 870220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex.
    Lohmeier TE; Iliescu R; Dwyer TM; Irwin ED; Cates AW; Rossing MA
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H402-9. PubMed ID: 20511410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.
    Lincevicius GS; Shimoura CG; Nishi EE; Perry JC; Casarini DE; Gomes GN; Bergamaschi CT; Campos RR
    Am J Hypertens; 2015 Sep; 28(9):1083-90. PubMed ID: 25628418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic potentiation of vasoconstrictor hypertension by adrenocorticotropic hormone.
    Lohmeier TE; Carroll RG
    Hypertension; 1982; 4(3 Pt 2):138-48. PubMed ID: 6279499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged activation of the baroreflex produces sustained hypotension.
    Lohmeier TE; Irwin ED; Rossing MA; Serdar DJ; Kieval RS
    Hypertension; 2004 Feb; 43(2):306-11. PubMed ID: 14707159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired baroreflex sensitivity and responses to angiotensin converting enzyme inhibitor in salt-induced hypertension and its prevention by dietary calcium supplement in Sprague-Dawley rats.
    Ladipo CO; Egbe PE; Ibu JO
    Afr J Med Med Sci; 2006 Mar; 35(1):29-36. PubMed ID: 17209324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension.
    Dell'Oro R; Quarti-Trevano F; Seravalle G; Zanchettin F; Bertoli S; Airoldi F; Mancia G; Grassi G
    Hypertension; 2019 Oct; 74(4):903-909. PubMed ID: 31378103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension.
    Qingyan Z; Xuejun J; Yanhong T; Zixuan D; Xiaozhan W; Xule W; Zongwen G; Wei H; Shengbo Y; Congxin H
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):562-70. PubMed ID: 25804321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.